Cardiovascular Effects of Cannabis                     (news – undated)


Cannabinoids impair the formation of cholesteryl ester in cultured human cells. (full – 1981)                                 


Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. (full – 2005)                                 


Cannabis compound tackles blood vessel disease                    (news – 2005)


Medical marijuana: study shows that THC slows atherosclerosis                      (news – 2005)


Science: THC slows development of atherosclerosis in animal study                         (news – 2005)



NOT SO DOPEY           (news – 2005)


Marijuana Chemical Fights Hardened Arteries                (news – 2005)


Does Cannabis Hold the Key to Treating Cardiometabolic Disease              (full – 2006)


Cannabinoid receptors in atherosclerosis.                 (abst – 2006)


Towards a therapeutic use of selective CB2 cannabinoid receptor ligands for atherosclerosis.        (abst – 2006)                              


The Cannabinergic System as a Target for Anti-inflammatory Therapies                (abst – 2006)


Endocannabinoids and the haematological system             (full – 2007)


Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption         (full – 2007)


Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase.                                                              (full – 2007)


Cannabinoids and cardiovascular disease: the outlook for clinical treatments. (abst – 2007)   PPMCArticlePage.PPMCPubmedRA&linkpos=5


Cannabinoid receptors in acute and chronic complications of atherosclerosis (full – 2008)                           


Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases                                                          (full – 2008)


CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.                                                             (full – 2008)


Cholesterol-induced stimulation of platelet aggregation is prevented by a hempseed- enriched diet.         (abst – 2008)                 


The emerging role of the endocannabinoid system in cardiovascular disease (full – 2009)                         


Endocannabinoids and the Heart               (full – 2009)


CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages                                               (full – 2009)  4a971695b4fb


Cannabidiol-2′,6′-Dimethyl Ether, a Cannabidiol Derivative, Is a Highly Potent and Selective 15-Lipoxygenase Inhibitor.                                                           (abst – 2009) thyl_Ether_a_Cannabidiol_Derivative_Is_a_Highly_Potent_and_Selective_15_Lipoxygenase_Inhibitor_


Cannabinoids and atherosclerosis.                 (abst – 2009)  sis_


Medical Marijuana and Arteriosclerotic Heart Disease                 (news – 2009)


US Patent Application 20100158973 – THERAPEUTIC USES OF CANNABIDIOL

COMPOUNDS           (full – 2010)


WIN55212-2 ameliorates atherosclerosis associated with suppression of pro- inflammatory responses in ApoE-knockout mice.                                                                       (abst – 2010)


The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques                                         (full – 2011)


Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice            (full – 2011)


Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full – 2011)                        


Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice.                                                                      (full – 2011)


Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo.           (abst – 2011)       


The effect of dietary hempseed on atherogenesis and contractile function in aortae from hypercholesterolemic rabbits.                                                           (abst – 2011)


Cannabinoids and atherosclerotic coronary heart disease.                    (full – 2012)


Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice                                                            (full – 2012)


Targeting cannabinoid receptor CB(2 ) in cardiovascular disorders: promises and controversies.   (full – 2012)


The potential use of cannabidiol in the therapy of metabolic syndrome                    (abst – 2012)


Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology.                                                (abst – 2012)


Share a link for